The medical aesthetics market is experiencing strong growth as demand rises for minimally invasive cosmetic procedures to enhance appearance and confidence. Services include injectables (like Botox and dermal fillers), laser treatments (for skin rejuvenation, hair removal), body contouring, and aesthetic devices. Consumer awareness, technological innovation, and evolving beauty standards are fueling market expansion. As treatments become safer, more affordable, and widely available, the medical aesthetics industry is poised for continued global growth.

According to Fortune Business Insights, the global medical aesthetics market was valued at USD 22.84 billion in 2023. The market is projected to grow from USD 25.48 billion in 2024 to USD 67.89 billion by 2032, exhibiting a CAGR of 13.0% during the forecast period. In 2023, North America dominated the medical aesthetics market with a market share of 53.77%.

Top Players Shaping the Future

• Sisram Medical Ltd (Israel)
• Merz Pharma (Germany)
• Apyx Medical (U.S.)
• AbbVie Inc. (U.S.)
• El.En. S.p.A. (Italy)
• Johnson & Johnson Services, Inc. (MENTOR) (U.S.)
• Candela Medical (U.S.)
• Cutera (U.S.)
• Bausch Health Companies Inc. (Canada)
• Sientra, Inc. (U.S.)

Key Industry Development

In November 2023, LUBEX rolled out the Sapphire ice‑cooling hair removal device, enabling safe and effective laser procedures in home settings—a pivotal move aligning with consumer demand for at-home treatments.

Market Drivers & Restraints

Market Drivers

• Increasing Demand for Minimally Invasive Procedures: More consumers are choosing quick, low-risk options such as botulinum toxin and dermal fillers, boosting non-surgical procedure numbers.
• Rising Male Participation: A growing number of men are opting for treatments. In 2022, approximately 1.37 million botulinum procedures were administered to men globally.